|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
COMMENTARY TO CONTROVERSIES IN NEPHROLOGY |
Division of Nephrology and Hypertension, Henry Ford Hospital, Detroit, Michigan
1 To whom correspondence should be addressed. E-mail: rparasu1{at}hfhs.org.
| Abstract |
|---|
Live kidney donation is considered safe; nevertheless, data supporting such claims are almost exclusively of white origin with very limited long-term outcomes in ethnic minority donors. This prospective observational study consisted of a total of 103 previous kidney donors (54 black and 49 white) with mean follow-up days of 743.5 ± 603.9 for white and 845.1 ± 668.5 for black donors. The black donors had a statistically significant greater loss of estimated GFR (eGFR; 39.8 ml/min per 1.73 m2) in comparison with white donors (30.4 ml/min per 1.73 m2; P = 0.001). In multivariate analysis, predonation eGFR of <100 ml/min and age at the time of donation were the significant predictors for postdonation eGFR <60 ml/min among black donors. Because eGFR using the Modification of Diet in Renal Disease 4 formula is not validated in live kidney donors, the significance of eGFR <60 ml/min per 1.73 m2 in previous kidney donors is unclear. Long-term prospective study with a gold standard method such as iothalamate GFR measurement is needed to define the actual decrease in eGFR after kidney donation.
This article has been cited by other articles:
![]() |
C. L. Davis, M. Cooper, W. L. Freeman, L. F. Ross, J. R. Thistlethwaite Jr., L. F.C. Dols, W. Weimar, J. N.M. IJzermans, H. N. Ibrahim, and A. J. Matas Long-Term Consequences of Kidney Donation N. Engl. J. Med., May 28, 2009; 360(22): 2370 - 2372. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |